SlideShare a Scribd company logo
Name : Bhagyashri Dnyaneshwar Taralkar.
Student of The Elite Institute Of Pharma Skills,Pune.
(www.elite.pharmaskills.com)
Guided By :Mrs. Archana Gawade .
History and Background of Good Clinical Practice
History and Background of Good Clinical Practice
Sulfanilamide Disaster
( 1937 )
Thalidomide Disaster
(1962)
Nazi experiments
(1940-1945)
Nurembergs Code
(1947)
1 2
3 4
5 6Tuskegee syphilis Study
(1932-1972)
Belmont Report
(1979)
 Gerhard Domagk (1932) : Discovered Red Azo Dye Prontosil a
Derivative of Sulfanilamide(1908).
It protected mice from lethal dose of staph and hemolytic
strep He got Nobel prize
 January 1932 Animal and Human studies demonstrated
sulfanilamide efficacy in streptococcal infection because first
synthesized in 1908 sulfanilamide was not patentable. Within
months Squib , Merck , Eli lily , Parke Davis each had received
AMA endorsement .
 In 1937 S.E Massengill Company of Bristol,
Tennesse , Founded by Samuel E . Massengill
began to produce sulfanilamide solution that had
not been available due to lack of appropriate
vehicle.
Sulfanilamide Disaster
S
1
 The FDA was notified , and an extensive
research was conducted to recover the
distributed medicines massengill company sent
out 1100 telegrams requesting the return of elixi
.FDA prohibited elixir .
Ys
s
.
 After investigating several possible solvents
Harold Watkins ,Massengill chief chemist formulated
raspberry flavor dissolved in
DEG added to sulfa drugs and it was
called Elixir Sulfanilamide and
company marketed the product.
 Using DEG as a solvent which is
poisonous To humans but Watkins
the company's chief pharmacist
was not aware of it
(although it was known at time)
 The toxicity of the product was never
tested and there were no regulations‘
requiring premarket safety testing of new drugs
 By early September1937 ,240 gallons of elixir
sulfanilamide had been manufactured by the
massengill company. The company started
distributing the medication in September 1937.
One of the major points of delivery of the drugs was
Tulsa, Oklahoma.
 By October 11, The American
Medical Association received a
report of several deaths caused by
medication
Facial
Paralysis
Coma Drowsiness Lethargy
Side Effects of Sulfanilamide Elixir.
Birth deformity Deformed hand
forearm
Feet Deformity
Thalidomide Disaster2
 The drug was found to be
associated with a congenital
abnormality causing severe birth
defects
 Thalidomide was marketed in USA
1957 for morning sickness and
nausea and soon became the drug of
choice to help pregnant women in
first trimester
 In 1964 (WMA) World Medical
Assembly has developed guidelines
called as Declaration of Helsinki(DOH)
for ethical conduct of studies
 Children's were born with
missing ( amelia ) or abnormal
( phocomelia )legs, arms , feet
and hands
 A series of law demonstrated that
large prescriber's had been relying
on manufacturers for the
information about drugs which was
based on inadequate testing
 Thalidomide syndrome triggered
world wide response Safety
monitoring system were set to
prevent this tragedy
FINLAND
Set of ethical principles
Regarding human experimentation
developed for the medical
community by the world medical
association (WMA).
WMA encourages other participants in medical research involving
human subject to adopt these principles
Declaration is addressed primarily to physician,
The Declaration of Geneva of the wma binds the physicians with
words
It is duty of physician to promote and safeguard the
health of patients including who are involved in research
And the International code of medical ethics declares that ,
A physician shall act in the patients best interest when providing
medical healthcare
The health of my patients will be my first consideration
main purpose: to understand causes , development and effect of
disease and improve preventive, diagnostic and therapeutic
intervention like safety , effectiveness , efficiency , accessibility
Declaration Of Helsinki
 Many of subject dies as a result of
experiments conducted by Nazis while many
others where after tests where completed
 In response , Drs . Leo Alexander and
Andrew Conway Ivy drafted a ten point
memorandum entitled permissible medical
Experiment that went to be known as
Nuremberg code
 The code called for such standards as
voluntary consent of patients, avoidance of
unnecessary pain and suffering and that must
be a belief that experimentation will not end
as death
Outcome of Nazi experiments
Nazi Experiment3
Freezing Experiments
High Altitude Experiments
Experiments of twins
Experiments with Poisons
Incendiary Bomb Experiments
High Altitude Experiments
Malaria Experiments
Mustard gas Experiments
Sulfonamide Experiments
Sea water Experiments
Sterilization Experiments
List of Nazi experiments
 Experimentation on twin children's in concentration
camp were created to show similarities and
differences in genetic of twins also to see human
body can be unnaturally manipulated.
 It was performed on over 1,500 sets of imprisoned
twins, fewer than 200 survived.
 Twins were arranged by age and sex and kept in
barracks between experiments which ranged from
injection of diiferent chemical sinto eye of twins to see
whether it could change the color and literally try
creating conjoined twins at Auschwitz concentration
camp in Poland in may1943
.Twins Experiments
Sea Water Experiment
From about July 1944 to about
september1944 Experiment
were conducted in Dachau
concentration camp to study
various method of making sea
water Drinkable
High Altitude Experiment
In early 1942 prisoners at
Dachau camp were used in
experiments to aid German
pilots who had eject at high
altitudes of the 200subjects ,
80 died outright others were
executed
Freezing Experiments
The result of this experiment
were publicized at the 1942
medical conference entitled
Medical Problems Arising from
Sea and winter
Sterilization experiments
From march 1941 to about Jan
1945, Sterilization experiments
were conducted at Auschwitz
,Ravvensbruck ,
It was a try to make a method of
minimum time and efforts for
sterilizing million of peoples
Animals experiments first.
Avoid suffering.
Protected from harm.
No intentional death or disability.
Subject free to stop.
Qualified,investigator.
Investigator will stop if harm occurs.
PRINCIPLES OF NUREMBERG CODE
Voluntary Consent.
Anticipate scientific benefits.
Nuremberg Code (1947)4
 Clinical study conducted in
Tuskegee , Alabama by US
public health service
.Tuskegee Syphilis Study(1932-1972)5
 Investigator recruited 399 poor, mostly
illiterate African American sharecroppers
with syphilis for research.
Study began as clinical trial of syphilis in the
Macon County Population.
Initially subjects studied for six to eight months
then treated with contemporary methods
 This included Salvarsan , mercurial
ointments and bismuth which were
somewhat effective , but quite toxic
, they were all that was available
 People were uninformed about disease
and said to be treated
for bad blood by 1947 penicillin
had become standard treatment for syphilis
 White people were given penicillin and black
were given placebo just to observe the
progression of fatal disease
By end of the study in 1972, only 74 of test
subjects were alive, 28of the original
 And write regulation governing studies invlving human participants On may16,
1997 president Bill Clinton formally apologized and held ceremony for Tuskegee
participants
 399 men had died of syphilis , 100 were dies of
related complications , 40 of their wives had been
infected and 19 children's were born with
congenital syphilis in 1974 congress passed the
National research act and created a commission to
study
Tuskegee Syphilis Study(1932-1972)
The report was issued on 30 September 1978 and published in federal register on 18
april1979 the report took its name from the Belmont conference center where the document
was drafted as a part
Three core principles are : respect for people, beneficence, and justice Three primary
applications like informed consent, assessment of risks and benefits and selection of
subjects
Today the Belmont report continues as an essential reference for institutional review board
That review HHS conducted proposal involving human subjects meets ethical foundation of
regulation
Created by the National Commission for the protection of human subjects of biomedical And
behavioral Research ,Ethical principles and guidelines for the protection of the human subjects of
research , report of the national commission for the protection of human subjects of biomedical and
behavioral research
Belmont Report6
202O
Thank you

More Related Content

What's hot

Good clinical practice by vijay
Good clinical practice by vijayGood clinical practice by vijay
Good clinical practice by vijayvijaypv
 
Basic structure of g.c.p
Basic structure of g.c.pBasic structure of g.c.p
Basic structure of g.c.p
Ashwani Kumar Singh
 
Gcp 2013
Gcp 2013Gcp 2013
Gcp 2013
Ghiath Alahmad
 
Basics of ich gcp campus kortrijk 2012 yge
Basics of ich gcp campus kortrijk 2012 ygeBasics of ich gcp campus kortrijk 2012 yge
Basics of ich gcp campus kortrijk 2012 ygeYves Geysels
 
The Declaration of Helsinki
The Declaration of HelsinkiThe Declaration of Helsinki
The Declaration of Helsinki
Pradeep H
 
140712 fsh presentation - good clinical practice hoang bao long
140712   fsh presentation - good clinical practice hoang bao long140712   fsh presentation - good clinical practice hoang bao long
140712 fsh presentation - good clinical practice hoang bao long
131IV14
 
Good Clinical Practice
Good Clinical PracticeGood Clinical Practice
Good Clinical Practice
Venkata SubbaReddy Avula
 
R&D and Good Clinical Practice (GCP) 011910
R&D and Good Clinical Practice (GCP) 011910R&D and Good Clinical Practice (GCP) 011910
R&D and Good Clinical Practice (GCP) 011910
Myron Pyzyk
 
Ich gcp
Ich gcpIch gcp
Ethical guidelines for biomedical research in human participants
Ethical guidelines for biomedical research  in human participantsEthical guidelines for biomedical research  in human participants
Ethical guidelines for biomedical research in human participantsgangireddysaisneha
 
ICH GCP
ICH GCPICH GCP
ICH GCP
Tamer Hifnawy
 
ICH and GCP by Naveen
ICH and GCP by NaveenICH and GCP by Naveen
ICH and GCP by Naveen
Naveen Kumar Upadhyay
 
The Nuremberg Code
The Nuremberg CodeThe Nuremberg Code
The Nuremberg Code
Himanshu Yadav
 
THE NUREMBERG CODE DECLARATION OF HELSINKI THE BELMONT REPORT
THE NUREMBERG CODEDECLARATION OF HELSINKITHE BELMONT REPORTTHE NUREMBERG CODEDECLARATION OF HELSINKITHE BELMONT REPORT
THE NUREMBERG CODE DECLARATION OF HELSINKI THE BELMONT REPORT
ANKITA PATEL
 
ICH-GCP Introduction
ICH-GCP IntroductionICH-GCP Introduction
ICH-GCP Introduction
Ansuman Parida
 
So you think you know GCP ...
So you think you know GCP ...So you think you know GCP ...
So you think you know GCP ...
Paul Below
 
Good Clinical Practice (GCP)
Good Clinical Practice (GCP)Good Clinical Practice (GCP)
Good Clinical Practice (GCP)
Devyani Joshi
 
Biowaste management
Biowaste managementBiowaste management
Biowaste management
ANIKETH SURVE
 
Helsinki declaration
Helsinki declarationHelsinki declaration
Helsinki declaration
Simran Narang
 

What's hot (20)

Combining GCP & GLP
Combining GCP & GLPCombining GCP & GLP
Combining GCP & GLP
 
Good clinical practice by vijay
Good clinical practice by vijayGood clinical practice by vijay
Good clinical practice by vijay
 
Basic structure of g.c.p
Basic structure of g.c.pBasic structure of g.c.p
Basic structure of g.c.p
 
Gcp 2013
Gcp 2013Gcp 2013
Gcp 2013
 
Basics of ich gcp campus kortrijk 2012 yge
Basics of ich gcp campus kortrijk 2012 ygeBasics of ich gcp campus kortrijk 2012 yge
Basics of ich gcp campus kortrijk 2012 yge
 
The Declaration of Helsinki
The Declaration of HelsinkiThe Declaration of Helsinki
The Declaration of Helsinki
 
140712 fsh presentation - good clinical practice hoang bao long
140712   fsh presentation - good clinical practice hoang bao long140712   fsh presentation - good clinical practice hoang bao long
140712 fsh presentation - good clinical practice hoang bao long
 
Good Clinical Practice
Good Clinical PracticeGood Clinical Practice
Good Clinical Practice
 
R&D and Good Clinical Practice (GCP) 011910
R&D and Good Clinical Practice (GCP) 011910R&D and Good Clinical Practice (GCP) 011910
R&D and Good Clinical Practice (GCP) 011910
 
Ich gcp
Ich gcpIch gcp
Ich gcp
 
Ethical guidelines for biomedical research in human participants
Ethical guidelines for biomedical research  in human participantsEthical guidelines for biomedical research  in human participants
Ethical guidelines for biomedical research in human participants
 
ICH GCP
ICH GCPICH GCP
ICH GCP
 
ICH and GCP by Naveen
ICH and GCP by NaveenICH and GCP by Naveen
ICH and GCP by Naveen
 
The Nuremberg Code
The Nuremberg CodeThe Nuremberg Code
The Nuremberg Code
 
THE NUREMBERG CODE DECLARATION OF HELSINKI THE BELMONT REPORT
THE NUREMBERG CODEDECLARATION OF HELSINKITHE BELMONT REPORTTHE NUREMBERG CODEDECLARATION OF HELSINKITHE BELMONT REPORT
THE NUREMBERG CODE DECLARATION OF HELSINKI THE BELMONT REPORT
 
ICH-GCP Introduction
ICH-GCP IntroductionICH-GCP Introduction
ICH-GCP Introduction
 
So you think you know GCP ...
So you think you know GCP ...So you think you know GCP ...
So you think you know GCP ...
 
Good Clinical Practice (GCP)
Good Clinical Practice (GCP)Good Clinical Practice (GCP)
Good Clinical Practice (GCP)
 
Biowaste management
Biowaste managementBiowaste management
Biowaste management
 
Helsinki declaration
Helsinki declarationHelsinki declaration
Helsinki declaration
 

Similar to Bhagyashri taralkar elite topic ppt

Ethics and nursing research
Ethics and nursing researchEthics and nursing research
Ethics and nursing research
Rafath Razia
 
History that lead to Pharmacovigilance.pptx
History that lead to Pharmacovigilance.pptxHistory that lead to Pharmacovigilance.pptx
History that lead to Pharmacovigilance.pptx
SirajSundaran
 
History of gcp
History of gcpHistory of gcp
History of gcp
Rajeev Sahai
 
History of _clinical_research (2)
History of _clinical_research (2)History of _clinical_research (2)
History of _clinical_research (2)
rahilkhan82
 
The Evolution of the Clinical Trials Process – A Brief History Lesson
The Evolution of the Clinical Trials Process – A Brief History LessonThe Evolution of the Clinical Trials Process – A Brief History Lesson
The Evolution of the Clinical Trials Process – A Brief History Lesson
Pradeep H
 
Lecture 4 history and ethical codes
Lecture 4  history and ethical codesLecture 4  history and ethical codes
Lecture 4 history and ethical codes
Ishah Khaliq
 
History ethical guide lines to clinical trial
History ethical guide lines to clinical trialHistory ethical guide lines to clinical trial
History ethical guide lines to clinical trial
Anju Thejkumar
 
Back to Tuskegee
Back to TuskegeeBack to Tuskegee
Back to Tuskegee
Jeanne Winstead
 
Unethical human experimentation in the United States - Wiki
Unethical human experimentation in the United States - WikiUnethical human experimentation in the United States - Wiki
Unethical human experimentation in the United States - Wiki
Not Relevant
 
Introduction to research ethics
Introduction to research ethicsIntroduction to research ethics
Introduction to research ethicsTamer Hifnawy
 
Ethics in health research
Ethics in health researchEthics in health research
Ethics in health research
Achyut Raj Pandey
 
ICH-GCP_E6_Gudelines_Section 1_History_Principles & Background of GCP.pptx
ICH-GCP_E6_Gudelines_Section 1_History_Principles & Background of GCP.pptxICH-GCP_E6_Gudelines_Section 1_History_Principles & Background of GCP.pptx
ICH-GCP_E6_Gudelines_Section 1_History_Principles & Background of GCP.pptx
Paramita Saha
 
Ethics in Clinical Research and Historical Perspective of Nazi Trials, Nuremb...
Ethics in Clinical Research and Historical Perspective of Nazi Trials, Nuremb...Ethics in Clinical Research and Historical Perspective of Nazi Trials, Nuremb...
Ethics in Clinical Research and Historical Perspective of Nazi Trials, Nuremb...
ShantanuThakre3
 
belmontreportbasics.ppt
belmontreportbasics.pptbelmontreportbasics.ppt
belmontreportbasics.ppt
IndreshBRajwade
 
Introduction and History of Clinical Research
Introduction and History of Clinical ResearchIntroduction and History of Clinical Research
Introduction and History of Clinical Research
ClinosolIndia
 
# 3rd lect research ethics
# 3rd lect  research ethics# 3rd lect  research ethics
# 3rd lect research ethics
Dr. Eman M. Mortada
 
Medical Ethics
 Medical Ethics Medical Ethics
Medical Ethics
Mona Mofti
 
History of epidemiology
History of epidemiologyHistory of epidemiology
History of epidemiology
ImroseRashid
 

Similar to Bhagyashri taralkar elite topic ppt (20)

Ethics and nursing research
Ethics and nursing researchEthics and nursing research
Ethics and nursing research
 
History that lead to Pharmacovigilance.pptx
History that lead to Pharmacovigilance.pptxHistory that lead to Pharmacovigilance.pptx
History that lead to Pharmacovigilance.pptx
 
History of gcp
History of gcpHistory of gcp
History of gcp
 
History of _clinical_research (2)
History of _clinical_research (2)History of _clinical_research (2)
History of _clinical_research (2)
 
Ethical issues in research 2
Ethical issues in research 2Ethical issues in research 2
Ethical issues in research 2
 
The Evolution of the Clinical Trials Process – A Brief History Lesson
The Evolution of the Clinical Trials Process – A Brief History LessonThe Evolution of the Clinical Trials Process – A Brief History Lesson
The Evolution of the Clinical Trials Process – A Brief History Lesson
 
Gcp final
Gcp finalGcp final
Gcp final
 
Lecture 4 history and ethical codes
Lecture 4  history and ethical codesLecture 4  history and ethical codes
Lecture 4 history and ethical codes
 
History ethical guide lines to clinical trial
History ethical guide lines to clinical trialHistory ethical guide lines to clinical trial
History ethical guide lines to clinical trial
 
Back to Tuskegee
Back to TuskegeeBack to Tuskegee
Back to Tuskegee
 
Unethical human experimentation in the United States - Wiki
Unethical human experimentation in the United States - WikiUnethical human experimentation in the United States - Wiki
Unethical human experimentation in the United States - Wiki
 
Introduction to research ethics
Introduction to research ethicsIntroduction to research ethics
Introduction to research ethics
 
Ethics in health research
Ethics in health researchEthics in health research
Ethics in health research
 
ICH-GCP_E6_Gudelines_Section 1_History_Principles & Background of GCP.pptx
ICH-GCP_E6_Gudelines_Section 1_History_Principles & Background of GCP.pptxICH-GCP_E6_Gudelines_Section 1_History_Principles & Background of GCP.pptx
ICH-GCP_E6_Gudelines_Section 1_History_Principles & Background of GCP.pptx
 
Ethics in Clinical Research and Historical Perspective of Nazi Trials, Nuremb...
Ethics in Clinical Research and Historical Perspective of Nazi Trials, Nuremb...Ethics in Clinical Research and Historical Perspective of Nazi Trials, Nuremb...
Ethics in Clinical Research and Historical Perspective of Nazi Trials, Nuremb...
 
belmontreportbasics.ppt
belmontreportbasics.pptbelmontreportbasics.ppt
belmontreportbasics.ppt
 
Introduction and History of Clinical Research
Introduction and History of Clinical ResearchIntroduction and History of Clinical Research
Introduction and History of Clinical Research
 
# 3rd lect research ethics
# 3rd lect  research ethics# 3rd lect  research ethics
# 3rd lect research ethics
 
Medical Ethics
 Medical Ethics Medical Ethics
Medical Ethics
 
History of epidemiology
History of epidemiologyHistory of epidemiology
History of epidemiology
 

Recently uploaded

Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 

Recently uploaded (20)

Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 

Bhagyashri taralkar elite topic ppt

  • 1. Name : Bhagyashri Dnyaneshwar Taralkar. Student of The Elite Institute Of Pharma Skills,Pune. (www.elite.pharmaskills.com) Guided By :Mrs. Archana Gawade . History and Background of Good Clinical Practice
  • 2. History and Background of Good Clinical Practice Sulfanilamide Disaster ( 1937 ) Thalidomide Disaster (1962) Nazi experiments (1940-1945) Nurembergs Code (1947) 1 2 3 4 5 6Tuskegee syphilis Study (1932-1972) Belmont Report (1979)
  • 3.  Gerhard Domagk (1932) : Discovered Red Azo Dye Prontosil a Derivative of Sulfanilamide(1908). It protected mice from lethal dose of staph and hemolytic strep He got Nobel prize  January 1932 Animal and Human studies demonstrated sulfanilamide efficacy in streptococcal infection because first synthesized in 1908 sulfanilamide was not patentable. Within months Squib , Merck , Eli lily , Parke Davis each had received AMA endorsement .  In 1937 S.E Massengill Company of Bristol, Tennesse , Founded by Samuel E . Massengill began to produce sulfanilamide solution that had not been available due to lack of appropriate vehicle. Sulfanilamide Disaster S 1
  • 4.  The FDA was notified , and an extensive research was conducted to recover the distributed medicines massengill company sent out 1100 telegrams requesting the return of elixi .FDA prohibited elixir . Ys s .  After investigating several possible solvents Harold Watkins ,Massengill chief chemist formulated raspberry flavor dissolved in DEG added to sulfa drugs and it was called Elixir Sulfanilamide and company marketed the product.  Using DEG as a solvent which is poisonous To humans but Watkins the company's chief pharmacist was not aware of it (although it was known at time)  The toxicity of the product was never tested and there were no regulations‘ requiring premarket safety testing of new drugs  By early September1937 ,240 gallons of elixir sulfanilamide had been manufactured by the massengill company. The company started distributing the medication in September 1937. One of the major points of delivery of the drugs was Tulsa, Oklahoma.  By October 11, The American Medical Association received a report of several deaths caused by medication
  • 5. Facial Paralysis Coma Drowsiness Lethargy Side Effects of Sulfanilamide Elixir.
  • 6. Birth deformity Deformed hand forearm Feet Deformity Thalidomide Disaster2
  • 7.  The drug was found to be associated with a congenital abnormality causing severe birth defects  Thalidomide was marketed in USA 1957 for morning sickness and nausea and soon became the drug of choice to help pregnant women in first trimester  In 1964 (WMA) World Medical Assembly has developed guidelines called as Declaration of Helsinki(DOH) for ethical conduct of studies  Children's were born with missing ( amelia ) or abnormal ( phocomelia )legs, arms , feet and hands  A series of law demonstrated that large prescriber's had been relying on manufacturers for the information about drugs which was based on inadequate testing  Thalidomide syndrome triggered world wide response Safety monitoring system were set to prevent this tragedy
  • 8. FINLAND Set of ethical principles Regarding human experimentation developed for the medical community by the world medical association (WMA). WMA encourages other participants in medical research involving human subject to adopt these principles Declaration is addressed primarily to physician, The Declaration of Geneva of the wma binds the physicians with words It is duty of physician to promote and safeguard the health of patients including who are involved in research And the International code of medical ethics declares that , A physician shall act in the patients best interest when providing medical healthcare The health of my patients will be my first consideration main purpose: to understand causes , development and effect of disease and improve preventive, diagnostic and therapeutic intervention like safety , effectiveness , efficiency , accessibility Declaration Of Helsinki
  • 9.  Many of subject dies as a result of experiments conducted by Nazis while many others where after tests where completed  In response , Drs . Leo Alexander and Andrew Conway Ivy drafted a ten point memorandum entitled permissible medical Experiment that went to be known as Nuremberg code  The code called for such standards as voluntary consent of patients, avoidance of unnecessary pain and suffering and that must be a belief that experimentation will not end as death Outcome of Nazi experiments Nazi Experiment3
  • 10. Freezing Experiments High Altitude Experiments Experiments of twins Experiments with Poisons Incendiary Bomb Experiments High Altitude Experiments Malaria Experiments Mustard gas Experiments Sulfonamide Experiments Sea water Experiments Sterilization Experiments List of Nazi experiments
  • 11.  Experimentation on twin children's in concentration camp were created to show similarities and differences in genetic of twins also to see human body can be unnaturally manipulated.  It was performed on over 1,500 sets of imprisoned twins, fewer than 200 survived.  Twins were arranged by age and sex and kept in barracks between experiments which ranged from injection of diiferent chemical sinto eye of twins to see whether it could change the color and literally try creating conjoined twins at Auschwitz concentration camp in Poland in may1943 .Twins Experiments
  • 12. Sea Water Experiment From about July 1944 to about september1944 Experiment were conducted in Dachau concentration camp to study various method of making sea water Drinkable High Altitude Experiment In early 1942 prisoners at Dachau camp were used in experiments to aid German pilots who had eject at high altitudes of the 200subjects , 80 died outright others were executed Freezing Experiments The result of this experiment were publicized at the 1942 medical conference entitled Medical Problems Arising from Sea and winter Sterilization experiments From march 1941 to about Jan 1945, Sterilization experiments were conducted at Auschwitz ,Ravvensbruck , It was a try to make a method of minimum time and efforts for sterilizing million of peoples
  • 13. Animals experiments first. Avoid suffering. Protected from harm. No intentional death or disability. Subject free to stop. Qualified,investigator. Investigator will stop if harm occurs. PRINCIPLES OF NUREMBERG CODE Voluntary Consent. Anticipate scientific benefits. Nuremberg Code (1947)4
  • 14.  Clinical study conducted in Tuskegee , Alabama by US public health service .Tuskegee Syphilis Study(1932-1972)5  Investigator recruited 399 poor, mostly illiterate African American sharecroppers with syphilis for research. Study began as clinical trial of syphilis in the Macon County Population. Initially subjects studied for six to eight months then treated with contemporary methods  This included Salvarsan , mercurial ointments and bismuth which were somewhat effective , but quite toxic , they were all that was available  People were uninformed about disease and said to be treated for bad blood by 1947 penicillin had become standard treatment for syphilis
  • 15.  White people were given penicillin and black were given placebo just to observe the progression of fatal disease By end of the study in 1972, only 74 of test subjects were alive, 28of the original  And write regulation governing studies invlving human participants On may16, 1997 president Bill Clinton formally apologized and held ceremony for Tuskegee participants  399 men had died of syphilis , 100 were dies of related complications , 40 of their wives had been infected and 19 children's were born with congenital syphilis in 1974 congress passed the National research act and created a commission to study Tuskegee Syphilis Study(1932-1972)
  • 16. The report was issued on 30 September 1978 and published in federal register on 18 april1979 the report took its name from the Belmont conference center where the document was drafted as a part Three core principles are : respect for people, beneficence, and justice Three primary applications like informed consent, assessment of risks and benefits and selection of subjects Today the Belmont report continues as an essential reference for institutional review board That review HHS conducted proposal involving human subjects meets ethical foundation of regulation Created by the National Commission for the protection of human subjects of biomedical And behavioral Research ,Ethical principles and guidelines for the protection of the human subjects of research , report of the national commission for the protection of human subjects of biomedical and behavioral research Belmont Report6